Penile cancer, while rare, is a critical public health issue due to its profound impact on
patients and the complexities of its management. The disease's multifactorial etiology …

Background and objective TP53 loss-of-function (TP53LOF) mutations might be a driver of
poor prognosis and chemoresistance in both human papillomavirus (HPV)-independent …

Introduction Penile squamous cell carcinoma (PSCC), a rare genitourinary cancer, is
associated with poor outcomes due to limited treatment effectiveness, especially in …

Background Penile squamous cell carcinoma (PSCC) is a rare malignancy. However, in
developing countries the incidence rate is higher. The understanding of molecular …

Penile cancer (PC), although rare, poses significant challenges in both diagnosis and
treatment. 1, 2 Penile squamous cell carcinoma (PSCC) represents the most common …

Penile carcinoma is a relatively rare malignancy with a prevalence of less than 1 per
100,000 men per year, with over 2000 new cases annually in the United States. 1, 2 Several …

Introduction Penile squamous cell carcinoma (PSCC) is a rare tumor with an aggressive
behavior. The Meet-URO 23/I-RARE registry includes rare genitourinary malignancies. We …

Introduction Advanced penile squamous cell carcinoma (pSCC) is a rare and aggressive
malignancy with a poor prognosis and an unmet need for biomarkers. We performed a …

Infection with high-risk human papillomavirus (HPV) accounts for nearly all cervical cancers
(CESC), a subset of other anogenital squamous cancers, and increasing rates of head and …

RESUMO O câncer de pênis (CPE) é um tumor raro, que acomete cerca de 2% da
população masculina. O aumento da incidência da doença está relacionado às baixas …